ATE483811T1 - Kontrollierte produktion und zuführung biologisch aktiver stoffe durch darmbakterien - Google Patents
Kontrollierte produktion und zuführung biologisch aktiver stoffe durch darmbakterienInfo
- Publication number
- ATE483811T1 ATE483811T1 AT06701043T AT06701043T ATE483811T1 AT E483811 T1 ATE483811 T1 AT E483811T1 AT 06701043 T AT06701043 T AT 06701043T AT 06701043 T AT06701043 T AT 06701043T AT E483811 T1 ATE483811 T1 AT E483811T1
- Authority
- AT
- Austria
- Prior art keywords
- biologically active
- supply
- active substances
- intestinal bacteria
- controlled production
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title abstract 3
- 239000013543 active substance Substances 0.000 title 1
- 230000000968 intestinal effect Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 abstract 1
- 230000037213 diet Effects 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 229920001221 xylan Polymers 0.000 abstract 1
- 150000004823 xylans Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0501540.9A GB0501540D0 (en) | 2005-01-25 | 2005-01-25 | Controlled production and delivery of biologically active agents by gut bacteria |
| PCT/GB2006/000222 WO2006079790A2 (en) | 2005-01-25 | 2006-01-24 | Controlled production and delivery of biologically active agents by gut bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE483811T1 true ATE483811T1 (de) | 2010-10-15 |
Family
ID=34259652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06701043T ATE483811T1 (de) | 2005-01-25 | 2006-01-24 | Kontrollierte produktion und zuführung biologisch aktiver stoffe durch darmbakterien |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7988961B2 (enExample) |
| EP (1) | EP1841875B1 (enExample) |
| JP (1) | JP4989490B2 (enExample) |
| KR (1) | KR101291960B1 (enExample) |
| AT (1) | ATE483811T1 (enExample) |
| CA (1) | CA2640343C (enExample) |
| DE (1) | DE602006017331D1 (enExample) |
| ES (1) | ES2353721T3 (enExample) |
| GB (1) | GB0501540D0 (enExample) |
| WO (1) | WO2006079790A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008317000B2 (en) * | 2007-10-26 | 2014-10-23 | Brenda E. Moore | Probiotic compositions and methods for inducing and supporting weight loss |
| EP2258844A1 (en) | 2009-05-28 | 2010-12-08 | Helmholtz Zentrum Für Infektionsforschung | Tumour-specific bacterial promoter elements |
| CN102462837B (zh) * | 2010-11-19 | 2016-08-03 | 生物林格斯Ip有限公司 | 抗炎组合物 |
| US10047405B2 (en) | 2013-12-20 | 2018-08-14 | President And Fellows Of Harvard College | Engineered genetic enteric sensor bacteria and uses thereof |
| US9688967B2 (en) | 2014-12-05 | 2017-06-27 | Synlogic, Inc. | Bacteria engineered to treat diseases associated with hyperammonemia |
| WO2016106343A1 (en) * | 2014-12-22 | 2016-06-30 | Massachusetts Institute Of Technology | Probiotic organisms for diagnosis, monitoring, and treatment of inflammatory bowel disease |
| US20160206666A1 (en) | 2014-12-22 | 2016-07-21 | Synlogic, Inc. | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier |
| JP7095993B2 (ja) * | 2015-03-02 | 2022-07-05 | シンロジック オペレーティング カンパニー インコーポレイテッド | 消化管炎症低下および／または消化管粘膜バリア強化の利益を享受する疾患処置のために操作された細菌 |
| EP3294760B1 (en) | 2015-05-13 | 2021-03-24 | Synlogic Operating Company, Inc. | Bacteria engineered to reduce hyperphenylalaninemia |
| US11685925B2 (en) | 2015-10-30 | 2023-06-27 | Synlogic Operating Company, Inc. | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier |
| AU2016356684C1 (en) | 2015-11-16 | 2022-11-10 | Synlogic Operating Company, Inc. | Bacteria engineered to reduce hyperphenylalaninemia |
| US11766461B2 (en) | 2016-04-20 | 2023-09-26 | The Board of Trustees of the Stanford Junior | Compositions and methods for nucleic acid expression and protein secretion in Bacteroides |
| EP3554518A4 (en) | 2016-12-15 | 2020-07-29 | The Board of Trustees of the Leland Stanford Junior University | COMPOSITIONS AND METHODS FOR MODULATING THE GROWTH OF A GENETICALLY MODIFIED INTESTINAL BACTERIAL CELL |
| WO2018152133A1 (en) * | 2017-02-14 | 2018-08-23 | California Institute Of Technology | Modulation of microbial synthesis of 4-etylphenol and 4-ethylphenol sulfate in behavior and disease |
| WO2018152306A1 (en) * | 2017-02-15 | 2018-08-23 | President And Fellows Of Harvard College | Modulation of host immune cell populations using gut microbiota |
| WO2018183685A1 (en) * | 2017-03-29 | 2018-10-04 | President And Fellows Of Harvard College | Methods of regulating gene expression in a cell |
| BR112021011221A2 (pt) | 2018-12-10 | 2021-08-31 | Novome Biotechnologies, Inc. | Métodos e composições para tratar hiperoxalúria |
| JP2023518184A (ja) | 2020-03-20 | 2023-04-28 | シンロジック オペレーティング カンパニー インコーポレイテッド | 高フェニルアラニン血症を軽減するように遺伝子改変された微生物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0569604A1 (en) * | 1992-04-07 | 1993-11-18 | Societe Des Produits Nestle S.A. | Integrative gene-expression in Streptococcus salivarius ssp.thermophilus |
| ATE356217T1 (de) * | 1999-09-10 | 2007-03-15 | Secr Defence | Rekombinante mikroorganismen |
| JP2001275680A (ja) * | 2000-03-31 | 2001-10-09 | Yakult Honsha Co Ltd | β−１，３−キシラナーゼ遺伝子、該遺伝子を導入した微生物、及びβ−１，３−キシラナーゼの製造法 |
| JP2003144200A (ja) * | 2001-11-07 | 2003-05-20 | Yakult Honsha Co Ltd | バクテロイデスグループ細菌用プローブおよびこれを用いた検出方法 |
-
2005
- 2005-01-25 GB GBGB0501540.9A patent/GB0501540D0/en not_active Ceased
-
2006
- 2006-01-24 JP JP2007551749A patent/JP4989490B2/ja not_active Expired - Fee Related
- 2006-01-24 KR KR1020077019503A patent/KR101291960B1/ko not_active Expired - Fee Related
- 2006-01-24 DE DE602006017331T patent/DE602006017331D1/de active Active
- 2006-01-24 US US11/814,739 patent/US7988961B2/en not_active Expired - Fee Related
- 2006-01-24 WO PCT/GB2006/000222 patent/WO2006079790A2/en not_active Ceased
- 2006-01-24 EP EP06701043A patent/EP1841875B1/en not_active Not-in-force
- 2006-01-24 ES ES06701043T patent/ES2353721T3/es active Active
- 2006-01-24 AT AT06701043T patent/ATE483811T1/de not_active IP Right Cessation
- 2006-01-24 CA CA2640343A patent/CA2640343C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2353721T3 (es) | 2011-03-04 |
| GB0501540D0 (en) | 2005-03-02 |
| JP4989490B2 (ja) | 2012-08-01 |
| JP2008527988A (ja) | 2008-07-31 |
| WO2006079790A2 (en) | 2006-08-03 |
| CA2640343A1 (en) | 2006-08-03 |
| DE602006017331D1 (de) | 2010-11-18 |
| EP1841875B1 (en) | 2010-10-06 |
| EP1841875A2 (en) | 2007-10-10 |
| WO2006079790A3 (en) | 2006-12-21 |
| KR101291960B1 (ko) | 2013-08-09 |
| CA2640343C (en) | 2014-01-14 |
| US20080131402A1 (en) | 2008-06-05 |
| KR20070108882A (ko) | 2007-11-13 |
| US7988961B2 (en) | 2011-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE483811T1 (de) | Kontrollierte produktion und zuführung biologisch aktiver stoffe durch darmbakterien | |
| BR112012017345A2 (pt) | "composições e métodos de pgl para a produção aumentada de isopreno e outros produtos com 6-fosfogliconolactonase (pgl)" | |
| MX2009013137A (es) | Metodos para seleccionar polipeptidos resistentes a la proteasa. | |
| PE20130593A1 (es) | DOMINIOS DE FIBRONECTINA TIPO III A LA DECIMA (10Fn3) MODIFICADOS DE UNION A SEROALBUMINA | |
| EA201171220A1 (ru) | Мутанты fgf21 и их применение | |
| EA201001883A1 (ru) | Мутанты fgf21 и их применение | |
| CL2012000063A1 (es) | Polipéptido factor ix (fix) o un fragmento del mismo porque comprende la modificación de un aminoácido; vector; célula; método para expresar el polipéptido fix; composición farmacéutica; uso de la composición para tratar enfermedades trombóticas, hemorrágicas y coagulación intravascular diseminada (cid) (div. sol. 1796-07). | |
| EA201590525A1 (ru) | Слитые белки для лечения метаболического синдрома | |
| NZ596658A (en) | Dig-10 insecticidal cry toxins | |
| MY159433A (en) | Fibrous materials and compositions | |
| DK2027152T3 (da) | Peptidfragmenter til induktion af syntese af ekstracellulære matrixproteiner | |
| BR112013010487A2 (pt) | novos substratos de coelenterazina e métodos de uso | |
| DE602007006492D1 (de) | Derivatisierung des granulozytenkoloniestimulierenden faktors | |
| MY180672A (en) | Ace2 polypeptide | |
| EP2195331A4 (en) | SYNTHETIC APOLIPOPROTEIN RECIPIENTS AND METHOD OF USE | |
| CO6430475A2 (es) | Polipéptidos que tienen actividad de celulasa | |
| MX2011007107A (es) | Composiciones de hidrolizado de proteina. | |
| NO20082345L (no) | Selektive VPAC2 reseptorpeptidagonister | |
| MY148447A (en) | Method for amidating polypeptides with basic aminoacid d-terminals by means of specific endoproteases | |
| EA201290542A1 (ru) | Модифицированные свиные соматотропиновые полипептиды и их применение | |
| ATE527284T1 (de) | Modifizierte antikörper-fragmente | |
| EA201290541A1 (ru) | Модифицированные бычьи соматотропиновые полипептиды и их применение | |
| ES2585185T3 (es) | Polipéptidos quiméricos y sus aplicaciones terapéuticas contra una infección por Flaviviridae | |
| SG10201803541TA (en) | Biologically active c-terminal arginine-containing peptides | |
| ATE505205T1 (de) | Polymerkonjugate von box-a von hmgb1 und box-a- varianten von hmgb1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |